Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Management of Hepatic Hydrothorax

Understanding Hepatic Hydrothorax

  • Hepatic hydrothorax is defined as the accumulation of transudative fluid in the pleural space in patients with cirrhosis and portal hypertension, affecting approximately 10% of individuals with advanced liver disease 1, 4
  • It forms due to small diaphragmatic defects (more often on the right side) through which ascites moves into the pleural space due to negative intrathoracic pressure during inspiration 5
  • Associated with poor prognosis, with median survival ranging from 8-12 months without liver transplantation 5, 6

First-Line Management

  • Initial treatment focuses on controlling ascites with sodium restriction and diuretics 5, 4
  • Therapeutic thoracentesis is indicated for symptomatic relief in patients with dyspnea but provides only temporary benefit 5, 7

Management of Refractory Hepatic Hydrothorax

  • Strong recommendation with moderate-quality evidence for TIPS in selected patients with refractory hepatic hydrothorax 2, 3, 7
  • Clinical response rates range from 42-79% with complete resolution of hydrothorax 1, 3
  • Meta-analysis of six studies (208 participants) showed an overall response rate of 56% 4
  • May serve as a bridge to liver transplantation 5

Patient Selection for TIPS

  • Careful patient selection is critical for successful outcomes 1, 3
  • Contraindications for TIPS include:
    • Bilirubin >50 μmol/L and platelets <75×10⁹/L 7
    • Pre-existing hepatic encephalopathy 3, 7
    • Active infection, severe cardiac failure, or severe pulmonary hypertension 3, 7

Alternative Options

  • Liver transplantation is the definitive treatment when indicated 5, 4
  • Pleurodesis may be considered for patients not eligible for TIPS or transplantation, but has high complication rates (up to 82%) 5
  • Thoracoscopic repair with mesh for well-defined diaphragmatic defects in selected patients 5

Clinical Pitfalls and Caveats

  • Most studies on TIPS for hepatic hydrothorax were conducted over a decade ago, with only one including PTFE-covered TIPS 1
  • No direct comparative studies between TIPS and standard treatment exist, limiting data on comparative survival 1, 3
  • Improvements in patient selection criteria may have reduced early post-TIPS mortality, but published data confirming this are lacking 1